Covid-19
WHO orders stoppage of use of hydroxychloroquine in treating coronavirus
The World Health Organisation is in another suspicious game over the controversial coronavirus ravaging the world to which countries are finding possible solutions to eradicate. WHO Director General, Tedros Adhanom Ghebreyesus, on Monday ordered the suspension of testing the malaria drug, hydroxychloroquine, on Covid-19 patients because of safety concerns.
US President, Donald Trump, had ordered the use of Hydroxycholoroquine as a possible treatment for coronavirus infection.
In Nigeria, Governor Bala Mohammed of Bauchi State, who once tested positive to coronavirus and under went treatment in isolation, had ordered the use of Hydroxycholoroquine for treatment of coronavirus patients in the state; insisting that he takes responsibility of any casualty in the use of the drug.
The WHO official, Tedros, had, however, declared that “The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board.”
The WHO DG stated that other arms of the trial – a major international initiative to hold clinical tests of potential treatments for the virus – were continuing.
The WHO has earlier opposed usage OF hydroxychloroquine to treat or prevent coronavirus infections, except as part of clinical trials.
The head of the WHO emergencies programme, Dr. Mike Ryan, explained that the decision to suspend trials of hydroxychloroquine had been taken out of “an abundance of caution.”
-
Latest3 days agoUS Immigration fees rise from October 16 as USCIS announces new charges
-
Football6 days agoHow David Beckham made $51.1m from 2026 World Cup, surpassing winners’ prize
-
Comments and Issues1 week agoFani-Kayode on Atiku: Separating claims from the record
-
Health6 days agoCOVID-19 Hospital care under scrutiny as US Senate hears patient, family testimonies
-
Business6 days agoOpenAI shelves GPT-6.1 astra release over safety concerns
-
Business2 days agoNigeria’s $55bn reserves raise fresh questions over naira value
-
Latest6 days agoADC’s 2027 Strategy: Who are the key players and what are their roles?
-
Latest6 days agoEl-Rufai continued detention revives debate over opposition, detention, political power


